263 related articles for article (PubMed ID: 30620007)
1. Implications of Na
Martín M; Geysels RC; Peyret V; Bernal Barquero CE; Masini-Repiso AM; Nicola JP
J Endocr Soc; 2019 Jan; 3(1):222-234. PubMed ID: 30620007
[TBL] [Abstract][Full Text] [Related]
2. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
[TBL] [Abstract][Full Text] [Related]
3. An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism.
Bernal Barquero CE; Martín M; Geysels RC; Peyret V; Papendieck P; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2022 Jan; 32(1):19-27. PubMed ID: 34726525
[No Abstract] [Full Text] [Related]
4. The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane.
Martín M; Salleron L; Peyret V; Geysels RC; Darrouzet E; Lindenthal S; Bernal Barquero CE; Masini-Repiso AM; Pourcher T; Nicola JP
FASEB J; 2021 Aug; 35(8):e21681. PubMed ID: 34196428
[TBL] [Abstract][Full Text] [Related]
5. Novel Sodium/Iodide Symporter Compound Heterozygous Pathogenic Variants Causing Dyshormonogenic Congenital Hypothyroidism.
Martín M; Bernal Barquero CE; Geysels RC; Papendieck P; Peyret V; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2019 Jul; 29(7):1023-1026. PubMed ID: 31115276
[TBL] [Abstract][Full Text] [Related]
6. A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis.
Martín M; Modenutti CP; Gil Rosas ML; Peyret V; Geysels RC; Bernal Barquero CE; Sobrero G; Muñoz L; Signorino M; Testa G; Miras MB; Masini-Repiso AM; Calcaterra NB; Coux G; Carrasco N; Martí MA; Nicola JP
J Clin Endocrinol Metab; 2021 Jun; 106(7):1867-1881. PubMed ID: 33912899
[TBL] [Abstract][Full Text] [Related]
7. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
8. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Mutational Landscape of the Sodium/Iodide Symporter in Congenital Hypothyroidism.
Martín M; Nicola JP
Thyroid; 2021 Dec; 31(12):1776-1785. PubMed ID: 34514854
[No Abstract] [Full Text] [Related]
10. Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency.
Nicola JP; Reyna-Neyra A; Saenger P; Rodriguez-Buritica DF; Gamez Godoy JD; Muzumdar R; Amzel LM; Carrasco N
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1353-61. PubMed ID: 26204134
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
De La Vieja A; Dohan O; Levy O; Carrasco N
Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
[TBL] [Abstract][Full Text] [Related]
12. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer.
Cai X; Wang R; Tan J; Meng Z; Li N
Clin Transl Oncol; 2021 Dec; 23(12):2403-2414. PubMed ID: 34100218
[TBL] [Abstract][Full Text] [Related]
14. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
Dohán O; De la Vieja A; Paroder V; Riedel C; Artani M; Reed M; Ginter CS; Carrasco N
Endocr Rev; 2003 Feb; 24(1):48-77. PubMed ID: 12588808
[TBL] [Abstract][Full Text] [Related]
15. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
17. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
[TBL] [Abstract][Full Text] [Related]
18. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD.
Szinnai G; Kosugi S; Derrien C; Lucidarme N; David V; Czernichow P; Polak M
J Clin Endocrinol Metab; 2006 Apr; 91(4):1199-204. PubMed ID: 16418213
[TBL] [Abstract][Full Text] [Related]
19. Iodide transport defect: functional characterization of a novel mutation in the Na+/I- symporter 5'-untranslated region in a patient with congenital hypothyroidism.
Nicola JP; Nazar M; Serrano-Nascimento C; Goulart-Silva F; Sobrero G; Testa G; Nunes MT; Muñoz L; Miras M; Masini-Repiso AM
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1100-7. PubMed ID: 21565787
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: A Novel Sodium/Iodide Symporter Mutation, S356F, Causing Congenital Hypothyroidism.
Durgia H; Nicholas AK; Schoenmakers E; Dickens JA; Halanaik D; Sahoo J; Kamalanathan S; Schoenmakers N
Thyroid; 2022 Feb; 32(2):215-218. PubMed ID: 34806438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
